Abbott India Ltd vs Valiant Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 10, 2026

Key Highlights

The Latest Trading Price of Abbott India Ltd is ₹ 26478 as of 10 Jun 15:30 . The P/E Ratio of Abbott India Ltd is 0 as of March 2023 .The P/E Ratio of Valiant Laboratories Ltd is 0 as of March 2023 . The Market Cap of Abbott India Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Valiant Laboratories Ltd is ₹ 0 crore as of March 2023 . The revenue of Abbott India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Valiant Laboratories Ltd for the Mar '26 is ₹ 92.15 crore as compare to the Dec '25 revenue of ₹ 53.09 crore. This represent the growth of 73.57% The ebitda of Abbott India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Valiant Laboratories Ltd for the Mar '26 is ₹ 4.98 crore as compare to the Dec '25 ebitda of ₹ -0.26 crore. This represent the decline of -2015% The net profit of Abbott India Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Valiant Laboratories Ltd changed from ₹ -0.51 crore to ₹ 1.76 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Abbott India Ltd changed from 84.61 % on March 2021 to 71.36 % on March 2025 . This represents a CAGR of -3.35% over 5 yearsThe Dividend Payout of Valiant Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Abbott India Ltd

Abbott India Ltd Share Price Overview Abbott India Ltd share price history records the movement of the stock in various phases of the market.
Company developments, as well as the general trends in the pharmaceutical industry, have influenced this movement.
As a healthcare-oriented company, the stock tends to respond to fluctuations in the demand of drugs, regulatory activities, and the general mood of investors.
The past performance of the stock gives the investors an idea of how it has reacted to the change in earnings, product portfolio development, and significant company occurrences at various times. Long-Term Performance The stock price performance of Abbott India Ltd has seen phases of fluctuation over time, with a 18% CAGR over the last 10 years.
This reflects movement across different market conditions, with periods of strength and correction.

About Valiant Laboratories Ltd

Valiant Laboratories Limited was originally formed as a Partnership Firm as M/s.
Bharat Chemicals' through deed of partnership dated October 17, 1980.
The said Partnership Firm, M/s.
Bharat Chemicals thereafter converted into a Public Company to 'Valiant Laboratories Limited' via Certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies. The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol.
The Company gradually, commenced manufacturing of Paracetamol by late 1982.

FAQs for the comparison of Abbott India Ltd and Valiant Laboratories Ltd

Which company has a larger market capitalization, Abbott India Ltd or Valiant Laboratories Ltd?

Market cap of Abbott India Ltd is 56,267 Cr while Market cap of Valiant Laboratories Ltd is 380 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Valiant Laboratories Ltd?

The stock performance of Abbott India Ltd and Valiant Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Valiant Laboratories Ltd?

As of June 10, 2026, the Abbott India Ltd stock price is INR ₹26478.6. On the other hand, Valiant Laboratories Ltd stock price is INR ₹70.0.

How do dividend payouts of Abbott India Ltd and Valiant Laboratories Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Valiant Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.